Platelet-rich plasma enhanced MSCs repair for glycerin-induced acute kidney injury via AKT/Rab27 paracrine pathway

Platelet-rich plasma enhanced MSCs repair for glycerin-induced acute kidney injury via AKT/Rab27 paracrine pathway | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Platelet-rich plasma enhanced MSCs repair for glycerin-induced acute kidney injury via AKT/Rab27 paracrine pathway Cheng Ji, Jiahui Zhang, Zixuan Zhou, Hui Shi, wanzhu Liu, Fengtian Sun, and 4 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-33696/v2 This work is licensed under a CC BY 4.0 License Status: Posted Version 2 posted You are reading this latest preprint version Show more versions Abstract Background: Acute kidney injury (AKI) was defined by rapid deterioration of renal function, as a common complication in hospitalized patients. Among the recent therapeutic options, mesenchymal stem cells (MSCs) were considered a promising therapeutic strategy for damaged tissues repair. Platelet rich plasma (PRP) regulates stromal cells to repair tissue damage through the release of growth factors. Here we proposed a possible therapeutic use of human umbilical cord mesenchymal stem cells stimulated by platelet-rich plasma (PRP-MSCs) in glycerin-induced acute kidney injury murine model. Methods: In vivo, we constructed glycerin-induced acute kidney injury rat models. On day 1 post injury, rat received a tail vein injection of 1×10 6 MSCs and 1×10 6 PRP-MSCs. All animals were sacrificed at Day 3 after glycerin injection. In vitro, NRK-52E cells were damaged by 20% glycerol for 12 hours, after that NRK-52E incubated with MSCs and PRP-MSCs for 24 hours in transwell co-culture system, DMEM as a negative control. NRK-52E cells were harvested for apoptosis assay, Western blot, and quantitative real-time polymerase chain reaction (qRT-PCR). Then the number of MSCs exosomes stimulated by PRP was detected by confocal microscopy and Nanosight tracking analysis (NTA), PRP-MSCs-Ex (10mg/kg) and MSCs-Ex (10mg/kg) were injected intravenously, saline as control. The therapeutic effect of PRP-MSCs was evaluated by analyzing renal function (serum BUN, Creatinine), histopathological structure changes and apoptosis and proliferation of renal tubular cells. Results: In vivo and vitro studies confirmed that the PRP induced YAP nucleus expression to promoting the proliferation and reinforces the stemness of MSCs, and PRP could promoted the paracrine secretion of exosomes by MSCs to repair AKI though AKT/Rab27 pathway. Conclusions: Our results revealed that PRP stimulated MSCs paracrine pathway could effectively alleviate glycerin-induced acute kidney injury. Therefore, RPP pretreatment may be a new method to improve the therapeutic effect of MSCs. Critical Care & Emergency Medicine platelet-rich plasma MSCs AKT/Rab27 exosomes AKI Figures Figure 1 Figure 2 Figure 3 Figure 4 Figure 5 Background Acute renal failure was caused by a variety of factors, including hypoxia, mechanical trauma, surgery, drugs and inflammation, induced the decrease of glomerular filtration rate, the accumulation of blood creatinine, urea nitrogen and other metabolites which was characterized by a rapid deterioration of renal function [1, 2] . And resulted in the corresponding clinical manifestations of the syndrome, which was a common clinical critical emergency [3, 4] . Although the renal tissue exhibited an intrinsic ability to regenerate after injury, full recovery in most cases was not achieved [5] . So that, multiple therapy approaches for renal regeneration have being considered. Mesenchymal stem cells (MSCs) have considerable potential in regenerative medicine for their ability of renewal and differentiation into distinct cell types, among the new therapeutic options for AKI, and MSCs were gaining increasing interest for the treatment of kidney injury [6-8] . MSCs could be isolated from the bone marrow, umbilical cord, adipose tissues, and other adult tissues [9] . Our previous studies have showed hucMSCs could be favourable candidate for injured tissue repair [10, 11] . Moreover, the efficacy of stem cell-based therapy could be further improved by small-molecule. Small-molecule drugs have an important role in regulating stem cell fate and function, and facilitate the development of cell-based therapies [12, 13] . Platelet rich plasma (PRP) are fractions of blood plasma with platelet concentrations and the platelet content was 1.2×10 12 platelets/ml. PRP contains a lot of cytokines, for instance PDGF, VEGF, TGF-β, IGF-1 and so on [14,15] . Recently studies reported that PRP could enhance cell clone formation, maintain the adipogenic, chondrogenic and osteogenic differentiation capacity of stem cells, and maintain an immunosuppressive state [16, 17] . Based on these biologic functions, PRP have been widely investigated in regenerative medicine. It was reported that PRP alleviated multiple organs damage, particularly in the skin injury [18, 19] . However, the effect of PRP on MSCs-based kidney therapy had not been cleared. It remains unknown whether PRP-modified MSCs could showed a more efficient repairing ability than did MSCs in tissue injury. As we known glycerin was a kind of high permeable substance and intramuscular injection of glycerin causes local muscle necrosis and erythrolysis, and it was easy to enter renal tubules through glomeruli, caused acute renal tubule damage [20] . Therefore, AKI animal model was established by intramuscular injection of 50% solution of hypertonic glycerin. Our previous studies have shown that MCSs have certain advantages in tissue damage repair. Futhermore, there were reported that modified MSCs could play enhanced therapeutic roles in kidney dysfunction diseases. As an endogenous stimulator, PRP could enhance the therapeutic effective of MSCs? What was the mechanism of MSCs repairing injury? In addition, for modulating MSCs function, small stimulator compounds have several advantages, including the convenience in modifying their concentration, working duration, and rapid and reversible working effects. Here we investigated the effect of PRP-MSCs and MSCs on glycerin-induced AKI. Our results showed that PRP induced YAP nucleus expression to promoting proliferation and maintain the stemness of MSCs, and stimulated the paracrine exosomes of MSCs though activated AKT/Rab27 signaling pathway to inhibiting the apoptosis of renal tubular cells. RPP pretreatment may be a new method to improve the therapeutic effect of MSCs repair for glycerin-induced AKI. Materials And Methods The study was approved by the ethical committee of Jiangsu University (2014280). Cells Culture Fresh human umbilical cords were obtained from consenting mothers in the affiliated hospital of Jiangsu University. HucMSCs were isolated and identified as previously described [11] and cultured in serum-free Dulbecco’s modified Eagle’s medium (DMEM, Gibco, CA) with 10% fetal bovine serum (FBS, Excell), penicillin and streptomycin (Gibco). Platelet-rich plasma (PRP) was provided by the central blood bank of Zhenjiang city, Jiangsu, China. The primary concentration was 1.2×10 12 platelets/mL. In the following experiments, hucMSCs treated with 1×10 8 platelets/mL PRP 12 h, and then the stimulator (PRP medium) was remove, MSCs were cultured in DMEM for 24 hours and collected cells as PRP-MSCs, MSCs: hucMSCs treated with DMEM as the control. Rat renal tubular epithelial cell lines (NRK-52E) were purchased from Cell Bank (Chinese Academy of Sciences, Shanghai, China) and maintained in high-glucose Dulbecco’s modified Eagle’s medium (DMEM, Gibco) containing 10% FBS at 37℃ with 5% CO 2 . The cells at passage 3 were used for the following studies. Osteogenic and adipogenic differentiation in vitro MSCs and PRP-MSCs were seeded in 35-mm plates in an osteogenic differentiation medium (0.1 mM dexamethasone, 10 mM β-glycerophosphate, and 50 mg/L ascorbic acid) or adipogenic differentiation medium (Cyagen Biosciences, USA) for 2 weeks, according to the manufacturer’s instructions. After the induction, the osteogenic and adipogenic potential was evaluated through alkaline phosphatase, alizarin red and oil red O staining, respectively. Isolation and Characterization of PRP-MSC-Ex The supernatant of MSCs stimulated by PRP 12 hours was collected, to a certain volume then exosomes were extracted and purified [21] . The protein concentration, as the quantification of exosomes, was determined by using a BCA protein assay kit. The morphology of exosomes was observed by using transmission electron microscopy (FEITecnai 12, Philips, Netherlands). The size of exosomes was analyzed the NanoSight LM10 system (nanosight tracking analysis, UK). For in vivo, to investigate the roles of PRP-MSCs-Ex in AKI model, MSCs-Ex and PRP-MSCs-Ex (10mg/kg) were treatment for AKI model via tail vein injected. CM-DiR (sigma) labeled exosomes were incubated at 37 ℃ for 30 minutes, and the bio-distribution of exosomes was detected via IVIS Lumina system (Perkin Elmer, USA) in vivo. Glycerin-induced model of AKI Adult male Sprague-Dawley rats weighing 180-200g (provided by the experimental animal center, JiangSu University, Permit Number: 2014280) were selected, the in vivo experiments were conducted following the regulatory standards. All the experimental rats were reared in the environment of room temperature of about 26 ℃, and the room should be kept clean, ventilated and quiet. After feeding for one week, the experimental rats were divided into four groups according to the random number table: control group, glycerin group, MSCs group, PRP-MSCs group, 10 rats in each group. The AKI rat model was established as described previously [20] . As previously described, AKI was performed in rat by intramuscular injection of 50% solution of hypertonic glycerin (10mL/kg, Sigma) into inferior hindlimbs. On day 1 post injury, rat received a tail vein injection of 1×10 6 MSCs and 1×10 6 PRP-MSCs in 200 mL saline and the same volume of saline as control. All animals were sacrificed at Day 3 after glycerin injection. Renal function (serum BUN, Creatinine), histopathological structure changes and tubular cells apoptosis were evaluated. Western blotting Renal tissues or NRK-52E cells were lysed in a radioimmunoprecipitation assay buffer containing proteinase inhibitors. Protein samples were separated by SDS-polyacrylamide gel electrophoresis, transferred to the polyvinylidene difluoride membrane (Millipore), blocked in 5% skim milk, and incubated with primary antibodies and horseradish peroxidase-conjugated secondary antibodies (Invitrogen). Primary antibodies used in research were as following: Bax (1:200, Bioworld, USA), Actived-caspase3 (1:500, CST, USA), and β-actin (1:800, CST, USA). The secondary antibodies were HRP-conjugated goat anti-rabbit and goat anti-mouse antibodies (1:1500, CWBIO, China). TUNEL and immunohistochemistry staining For histologic analysis, the kidneys were prepared by perfusion of the rat through the left ventricle and slides of the kidney were prepared, fixed in 4% paraformaldehyde, embedded in paraffin and then cut into sections. We detected apoptosis cells by employing terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) staining according to the manufacturer’s protocol (Vazyme, USA). The sections were stained with hematoxylin and eosin (HE) staining, and the histological changes of renal tissues were observed under a microscope (DP73; Olympus, Tokyo, Japan). After inactivating endogenous enzymes by 10% H 2 O 2 with 30 minutes, the slices of kidney tissues and cells were incubated with actived-caspase3 antibody (1:100, CST, USA) overnight at 4°C, then incubated with biotinylated sheep anti-rabbit IgG. The signal was observed by DAB staining and hematoxylin counterstaining under microscope (DP73; Olympus, Tokyo, Japan). Immunofluorescence analysis MSCs and PRP-MSCs cells slide were placed in 4% paraformaldehyde at 4°C for 12 h. Then permeabilized with PBS solution containing 0.15% Triton X-100 for 30min and incubated with 5% bovine serum albumin (BSA) for 1h to block non-specific antibody binding. Primary antibody AKT (1:100, CST), Rab27 (1:100, CST), CD63 (exosomes marker) (1:50, CST) were incubated overnight, followed by incubation with Cy3-labeled (Red) anti-rabbit IgG (1: 200, invitrogen), FITC-labeled (Green) anti-rabbit IgG secondary antibody (1: 200, invitrogen) at 37°C for 30 min. The nuclei were counterstained with Hoechst 33342 (1:200; Sigma). The slides were visualized with Confocal microscope (DeltaVision Elite, GE, USA). Statistical analysis All data were shown as mean ± SD. Statistical analysis between groups was performed by GraphPad Prism 5.0 software (San Diego, USA). Statistical differences between two groups were determined by two-tailed paired Student’s t-test. In multiple groups (>2) were determined by one-way analysis, and variance followed by ANOVA Tukey’s post tests. * P <0.05 was considered statistically significant. Results Platelet-rich plasma enhanced the repairing effect of MSCs on glycerin-induced acute kidney injury In order to investigate the repairing effect of PRP-MSCs on acute renal injury, we constructed the AKI model by intramuscular injection of 50% hypertonic glycerol solution into the inferior hind limbs of rats (10 mL/kg), and to evaluating the repairing ability of PRP-MSCs in AKI model (Fig. 1a). Results showed that serum BUN and Creatinine levels increased markedly at Day 3 and remained at a high level after 50% glycerin injection. Compared with MSCs, PRP-MSCs transplantation reduced Creatinine levels (Fig. 1b and Fig. 1c). The histological evaluation of kidney sections in the glycerin group revealed the presence of intra-tubular protein casts and tubular epithelial cell necrosis. The number of casts and necrotic tubules was significantly reduced in MSCs and PRP-MSCs-treated rat confirming their beneficial effect, and PRP-MSCs was more effective than MSCs in alleviating the vacuoles of renal tubules (Fig. 1d). Moreover, the histological damage score of PRP-MSCs group was significantly lower than that of glycerin injury group, and the damage score of PRP-MSCs group was 40% lower than MSCs group (Fig. 1e). In rat kidney tissues, we used western blotting to detecting the expression of apoptosis-associated proteins. The results showed that though transplanting MSCs and PRP-MSCs decreased the expression of Bax and actived-caspase3, and the anti-apoptosis effect of PRP-MSCs group was more efficiency than MSCs group (Fig. 1f). In the pathological section of renal tissue, immunohistochemical staining further confirmed the most actived-caspase3 positive cells were glycerin groups, while the number of PRP-MSCs groups was significantly lower than that of MSCs group (Fig. 1g). Furthermore, TUNEL assay indicated that a reduced number of apoptotic cells in both MSCs and PRP-MSCs groups, and the PRP-MSCs group had fewer apoptotic cells than did MSCs group (Fig. 1h). These results indicated that PRP-MSCs showed more efficient repair ability than MSCs in glycerin-induced kidney injury. PRP-MSCs attenuated glycerin-induced NRK-52E cells apoptosis Histopathology showed that AKI mainly damaged renal tubules, therefore，in vitro experiment, we used 20% glycerol hypertonic medium-treated NRK-52E cells. After treating with glycerin for 12 h, there were a significantly increased number of apoptotic NRK-52E cells. Then, we established an in vitro transwell co-culture system to allow the transfer of EVs but to preclude direct cell contact and evaluated the effects of NRK-52E cells treated with the MSCs/PRP-MSCs for 24 hours (Fig. 2a). Then lysis and extraction protein in NRK-52E cells, western blotting analysis the expression of apoptosis-associated proteins and the results showed that Bax and actived-caspase3 significantly increased after glycerin treatment. Nevertheless, in the PRP-MSCs group, the expression levels of Bax and actived-caspase3 were lowest in NRK-52E cell (Fig. 2d). Corresponding to these, treatment with PRP-MSCs or MSCs could effectively reverse cells apoptosis and the number of apoptotic NRK-52E cells was least in the PRP-MSCs group by flow cytometry (Fig. 2c). The statistical result was shown in Fig. 2d. Immunohistochemical and TUNEL staining further confirmed the expression of actived-caspase3 and Bax the results were consistent with that by western blotting. Respectively, the number of actived-caspase3 and TUNEL-positive cells obviously increased after glycerin treatment, PRP-MSCs group had fewer positive cells than did MSCs group (Fig. 2e and 2f). In general, these results showed that PRP-MSCs could significantly inhibit glycerin-induced NRK-52E cells apoptosis compared with MSCs, which confirmed the role of the reno-protective. PRP promoted the proliferation and differentiation of MSCs In vivo and in vitro experiments, we confirmed the repair effect of PRP-MSCs in AKI model. Then, MSCs treated with 1×10 8 platelets/mL PRP 12 h, we observed that PRP could significantly promote the proliferation of MSCs (Fig. 3a). Being a key pathway involved in regeneration progression, YAP signaling controls organ size and regulates tissue cell regeneration [22, 23] . Immunohistochemistry showed that PRP induced YAP nucleus expression and promoted cell proliferation in MSCs (Fig. 3b). Then, we used western blotting and qRT-PCR analysis for stemness-associated proteins expression, at protein and gene level of Nanog, Sox2, Oct4 and Sall4 were increased in MSCs with PRP treatment (Fig. 3c and 3d). In vitro experiments, PRP induced adipogenic and osteogenic differentiation of MSCs, and the percentage of alizarin red positive cells in PRP group was higher than DMEM group, confirmed PRP could promote multi-directional differentiation of MSCs (Fig. 3e). Overall, these results suggest that PRP induced YAP nucleus expression and increased stemness-associated gene to promoting MSCs proliferation and differentiation. PRP promoted the paracrine secretion of MSCs exosomes though AKT/Rab27 pathway It is confirmed that PRP could promoted the proliferation and repair AKI of MSCs. Next, we explored the mechanism of PRP enhanced the repair of MSCs, recently research have reported that MSC exosomes (MSC-Ex) were the key paracrine component of MSCs, and shown to exert therapeutic effects on tissue injury [24, 25] . Therefore, we focused on the effect of PRP on the exosomes secretion of MSCs. AKT/Rab27 signaling pathway regulated the synthesis and secretion of exosomes [26] , in this experiment, our found that PRP stimulated AKT to enter the nucleus and the expression of Rab27 was increased (Fig. 4a and 4b). In the other side, the protein level of PRP-MSCs confirmed this result (Fig. 4c). Western blot results confirmed the higher expression of exosomal marker CD9, CD63 and CD81 in PRP-MSC-Ex (Fig. 4d). PRP stimulated the increase of CD63 in MSCs was observed with confocal microscope, which indicated that PRP promoted the secretion of exosomes (Fig. 4e). These results suggested that PRP might affect the secretion of MSC exosomes. We further analyzed, exosomes as cup-like spherical vesicles by using transmission electron microscopy (TEM) (Fig. 4f), MSC-Ex as nanoscale membrane vesicles, the size was determined to be 101.5 ± 24.3nm and PRP-MSC-Ex was 108.6 ± 33.6nm (mean ± SD) by nanoparticle tracking analysis (NTA), diluted 1000 times when measuring, so the concentration of MSC-Ex was 2.5×10 9 /ml and PRP-MSC-Ex was 5.1×10 9 /ml (Fig. 4g), and we found the shape and particle size of exosomes not changed by PRP stimulation, while PRP could increased the secretion of MSC-Ex twice (Fig. 4h). These results indicated that PRP promoted the paracrine secretion exosomes of MSCs though activated AKT/Rab27 pathway. PRP-MSC-Ex localization and repaired for renal injured tissue To determine the localization and bio-distribution of PRP-MSCs-Ex within injured renal tissue, exosomes were labeled with a fluorescent dye (DIR, 50μM) were injected intravenously and tracked by optical imaging (PerkinElmer, USA) in AKI mice. The performed 12 h after the administration of exosomes, revealed the presence of exosomes fluorescence signal in injury kidneys (Fig. 5a and Fig. S2a). Previously, we confirmed the orientation of exosomes in damaged tissues, next step we analyzed the role of the reno-protective factor. Compared with MSCs-Ex, PRP-MSCs-Ex transplantation reduced Bun and Creatinine levels in AKI model (Fig. S1c and Fig. S1d). Kidney histological revealed that the number of casts and necrotic tubules was significantly reduced in MSC-Ex and PRP-MSC-Ex treated rats (Fig. 5b). Similarly, the TUNEL analysis showed that the number of apoptotic cells in MSC-Ex group and PRP-MSC-Ex group were decreased, and the number of apoptotic cells in PRP-MSC-Ex group was significantly less than that in glycerin group (Fig. 5c). The expression of apoptosis-related proteins Bax and Actived-caspase3 in renal tissue were inhibited after PRP-MSC-Ex treatment (Fig. 5d). And the statistical analysis of the intervention effect of PRP-MSC-Ex was better than that of MSC-Ex group (Fig. 5e). In vitro experiments, flow cytometry results showed that MSC-Ex could effectively reduce the apoptosis of NRK-52E cells induced by glycerin, and the number of NRK-52E cells in PRP-MSC-Ex group decreased by 76.3% (Fig. 5f and 5g). In order to further determine this phenomenon, immunohistochemistry was used to detected the expression of activated-caspase3 positive cells after intervention, the number of positive cells in PRP-MSC-Ex group was significantly less than in injury group, and the positive cells were less than the MSC-Ex group (Fig. 5h). Western blotting results showed that the expression of Bax and actived-caspase3 decreased significantly after MSC-Ex treatment. Moreover, in PRP-MSC-Ex group, Bax and actived-caspase3 had the lowest expression level in NRK-52E cells (Fig. 5i). These results confirmed that the PRP-MSC-Ex had more beneficial effect compare with PRP-MSC. In general, these results showed that exosomes were the key component of MSC in the treatment of renal injury which could significantly inhibited the apoptosis of NRK-52E cells induced by glycerin, and confirmed the mechanism of PRP stimulated the secretion exosomes of MSC in the repair of acute renal injury. Discussion Kidney injury treatments have always been the intractable medical problem. The therapeutic methods so far were function-limited and if the treatment intervention was not timely, could deteriorate into chronic kidney disease, and many patients suffer from chronic pain for a long time [27] . Cell-based therapies and tissue regeneration are new approach to overcome the present limitations of kidney injury healing [28, 29] . MSCs were a promising therapeutic tool in regenerative medicine due to their self-renewal and multi-directional differentiation potency. Recently have a large number of studies showed that MSCs could repair cisplatin/glycerin-induced acute kidney injury [30] , ischemia/reperfusion-induced acute renal failure [31] , and unilateral ureteral obstruction-induced renal interstitial fibrosis [32] . Nevertheless, the transplanted MSCs also existed potential problem, most of them could not survive for a long time, only a few of them exist in the damaged kidney. The lower implantation and survival rates weakened the therapeutic effect of MSCs treatment. Therefore, in order to maximize the clinical application value of MSCs, we must take corresponding strategies to improve their therapeutic effect. One of the common strategies that improved the therapeutic effects of stem cell transplantation was pretreatment stem cells with small molecules drugs. Our recently studies showed that 3,3'-diindolylmethane stimulated exosomal Wnt11 autocrine signaling in MSCs to enhance wound healing [11] and resveratrol improved MSCs repair for cisplatin-induced AKI [33] . These studies proved that small-molecule drugs were potential candidates for stem cell manipulation in regenerative medicine. The effect of Platelet-rich plasma (PRP) on tissue healing has been mainly attributed to release of growth factors from platelets, such as PDGF, VEGF and TGF-β could promote cell proliferation and migration [34] . Recently, studies have reported that PRP could attract MSCs, then PRP enhanced cells repair and promote the initial healing of wounds and this phenomenon called the chemotactic effect [18] . However, the role of PRP pre-treatment in MSCs based therapy has not been characterized. In this study, we found that PRP-MSC improved renal function compared with MSC, as demonstrated by the decrease of serum creatinine and BUN levels, PRP stimulated MSC could inhibit apoptosis of renal tubular cells and as well as the decrease of histological injury score. MSC primed with PRP exhibited more effective repair effects than untreated MSC in glycerin-induced AKI models. These results indicated that PRP pre-treatment was safe, efficient and low cost, which was expected to emerge as a promising strategy to improve MSC-based therapy. The next step was to thinking about the mechanism of PRP promoting MSC to repair renal injury. As we know, YAP plays a key role in the control of tissue and cell proliferation and development [22, 35, 36] . Through the experiments PRP stimulated YAP protein to enter the nucleus which promoted the proliferation of MSC and the differentiation ability of osteoblasts and adipocytes. These information were suggested that appropriate amount of PRP could enhance the injury repair effective of MSC. Exosomes, one form of extracellular vesicles, have potential as mediators of intercellular message and play a major role in cell-to-cell communication, while therapeutic effects of human MSC-derived exosomes have been verified using a rodent model [21, 37, 38] . And then research team finding platelet-rich plasma improved the wound healing potential of mesenchymal stem cells through paracrine and metabolism alterations [39] . AKT/Rab27 pathway was involved in the regulation of exosomes synthesis and secretion [26, 40] . In this experiment, we found that PRP could increase two times number of MSC exsomes, without changing its morphology and particle size. And PRP stimulated paracrine secretion of MSCs exosomes by activating AKT/Rab27 pathway, DiR dye-labeled PRP-MSCs-Ex localized within the injured kidney and promoted the recovery of renal function, reduced the expression of injury markers. In the present study, we demonstrate that PRP induced YAP nucleus expression to promoting the proliferation and maintain the stemness of MSCs, and stimulated the paracrine secretion exosomes of MSCs to inhibiting the apoptosis of renal tubular cells by activating AKT/Rab27 signaling pathway. We propose an innovative use of PRP-MSC as a therapeutic strategy for renal regeneration. Conclusion This study reveals that PRP promoted the paracrine secretion of exosomes by MSCs to repair glycerin-induced AKI though AKT/Rab27 pathway. These findings confirm that RPP pretreatment could improved the therapeutic effect of MSCs on renal injury. Declarations Acknowledgements This work was supported by the National Natural Science Foundation of China (Grant no. 81871496), Zhenjiang Key Laboratory of High Technology Research on Exosomes Foundation and Transformation Application (Grant ss2018003), Key project of practice and innovation of college students in Jiangsu Province (201910299029Z), and project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (Phase III). Funding The National Natural Science Foundation of China (Grant no. 81871496); Zhenjiang Key Laboratory of High Technology Research on Exosomes Foundation and Transformation Application (Grant no. ss2018003). Availability of data and materials Not applicable. Authors’ contributions CJ: conception and design, collection and assembly of data, and manuscript writing. JZ: conception and design, data analysis and interpretation, and manuscript writing. XZ: conception and design, data analysis. HS: collection and/or assembly of data and data analysis. WL: collection and/or assembly of data and data analysis. FS: data analysis and interpretation. CZ: provision of study material and interpretation. LZ: data analysis and interpretation. XZ: data analysis and interpretation. HQ: study design, manuscript writing, and final approval of manuscript. All authors read and approved the final manuscript. Conflict of interest The authors declare that they have no conflict of interest. Consent for publication Not applicable. Ethical approval and consent to participate This study was approved by the ethical committee of Jiangsu University (2014280). Abbreviations Platelet-rich plasma (PRP) Mesenchymal stem cells (MSCs) Acute kidney injury (AKI) Mesenchymal stem cells-exosomes (MSCs-Ex) Quantitative real-time polymerase chain reaction (qRT-PCR) Nanoparticle tracking analysis (NTA) Immunohistochemistry (IHC) References Schrier RW, Wang W, Poole B, Mitra A. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest. 2004. 114, 5-14. Thiele RH, Isbell JM, Rosner MH. AKI associated with cardiac surgery. Clin J Am Soc Nephrol. 2015,10, 500-514. Rewa O, Bagshaw SM. Acute kidney injury-epidemiology, outcomes and economics. Nat Rev Nephrol. 2014.10, 193-207. Pozzoli S, Simonini M, Manunta P. Predicting acute kidney injury: current status and future challenges. J Nephrol. 2018. 31, 209-223. Anathhanam S, Lewington AJP. Acute Kidney Injury. J R Coll Physicians Edinb. 2013;43(4):323-8; quiz 329. Wang BY, Jia HY, Zhang B, Wang JJ, Ji C, Zhu XM, et al. Pre-incubation with hucMSC-exosomes prevents cisplatin-induced nephrotoxicity by activating autophagy. Stem Cell Res Ther. 2017,8;8(1):75. Swaminathan M, Stafford-Smith M, Chertow GM, Warnock DG, Paragamian V, Brenner RM, et al. Allogeneic mesenchymal stem cells for treatment of AKI after cardiac surgery. J Am Soc Nephrol. 2018, 29, 260-267. Yuan X, Wang X, Chen C, Zhou J, Han M. Bone mesenchymal stem cells ameliorate ischemia/reperfusion-induced damage in renal epithelial cells via microRNA-223. Stem Cell Res Ther. 2017, 8, 146. Jiang Y, Jahagirdar BN. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002,418:41-49. Zhang B, Shi Y, Gong A, Pan Z, Shi H, Yang H, et al. HucMSC exosome-delivered 14-3-3ζ orchestrates self-control of the wnt Response via modulation of YAP during cutaneous regeneration. Stem Cells. 2016;34(10):2485-2500 Shi H, Xu X, Zhang B,Xu J, Pan Z, Gong A, et al. 3,3'-Diindolylmethane stimulates exosomal Wnt11 autocrine signaling in human umbilical cordmesenchymal stem cells to enhance wound healing. Theranostics. 2017,10;7(6):1674-1688. Schugar RC, Robbins PD, Deasy BM. Small molecules in stem cell self- renewal and differentiation. Gene Ther. 2008,15, 126-135. Li W, Li K, Wei W. Chemical approaches to stem cell biology and therapeutics. Cell Stem Cell. 2013,13:270-283. Boswell SG, Cole BJ, Sundman EA, Karas V, Fortier LA. Platelet-rich plasma: a milieu of bioactive factors. Arthroscopy. 2012, 28(3): 429-439. Emer J. Platelet-rich plasma (PRP): current applications in dermatology. Skin Therapy Lett. 2019,24(5):1-6. Duan J, Kuang W, Tan J, Li H, Zhang Y, Hirotaka K, et al. Differential effects of platelet rich plasma and washed platelets on the proliferation of mouse MSC cells. Mol Biol Rep. 2011, 38(4): 2485-2490. Li H, Usas A, Poddar M, Chen CW, Thompson S, Ahani B, et al. Platelet-rich plasma promotes the proliferation of human muscle derived progenitor cells and maintains their stemness. PLoS One. 2013, 8(6): 64923. Guo S, Tao S, Yin W, Qi X, Yuan T, Zhang C. Exosomes derived from platelet-rich plasma promote the re-epithelization of chronic cutaneous wounds via activation of YAP in a diabetic rat model. Theranostics. 2017,1;7(1):81-96. Emer J. Platelets in wound healing and regenerative medicine. Platele. 2018, 29(6):556-568. Grange C, Papadimitriou E, Dimuccio V, Pastorino C, Molina J, O'Kelly R, et al. Urinary extracellular vesicles carrying klotho improve the recovery of renal function in an acute tubular injury model. Mol Ther. 2020, 5;28(2):490-502. Sun Y, Shi H, Yin S, Ji C, Zhang X, Zhang B, et al. Human mesenchymal stem cell derived exosomes alleviate type 2 diabetes mellitus by reversing peripheral insulin resistance and relieving β-cell destruction. ACS Nano. 2018,12, 7613-7628. Yu FX, Zhao B, Guan KL. Hippo pathway in organ size control, tissuehomeostasis, and cancer. Cell.2015,163,811-828. 23. Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, et al. Role of YAP/TAZ in mechanotransduction. Nature. 2011,474:179-183. Riazifar M, Mohammadi MR, Pone EJ, Yeri A, Lässer C, Segaliny AI, et al. Stem cell-derived exosomes as nanotherapeutics for autoimmune and neurodegenerative disorders. ACS Nano. 2019,13(6):6670-6688. Yan Y, Jiang W, Tan Y, Zou S, Zhang H, Mao F, et al. HucMSC exosome-derived GPX1 is required for the recovery of hepatic oxidant injury. Mol Ther. 2017,1;25(2):465-479. Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A, et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol. 2010,12(1):19-30. Xu L, Li X, Zhang F, Wu L, Dong Z, Zhang D. EGFR drives the progression of AKI to CKD through HIPK2 over expression. Theranostics. 2019,13;9(9):2712-2726. Li W, Li K, Wei W. Chemical approaches to stem cell biology and therapeutics. Cell Stem Cell. 2013;13:270-283. Barbara F, Griffin MD. Mesenchymal stromal cell-based therapies for acute kidney injury: Progress in the last decade. Kidney Int. 2020. 29;S0085-2538(20)30093-4. Fazekas B, Griffin MD. Mesenchymal stromal cell-based therapies for acute kidney injury: progress in the last decade. Kidney Int. 2020,97(6):1130-1140. Cao HM, Cheng YQ, Gao HQ, Zhuang J, Zhang W, Bian Q, et al. In vivo tracking of mesenchymal stem cell-derived extracellular vesicles improving mitochondrial function in renal ischemia-reperfusion injury. ACS Nano. 2020,28;14(4):4014-4026. Ji C, Zhang J, Zhu Y, Shi H, Yin S, Sun F, et al. Exosomes derived from hucMSC attenuate renal fibrosis through CK1δ/β-TRCP-mediated YAP degradation. Cell Death Dis. 2020,7;11(5):327. Zhang R, Yin L, Zhang B, Shi H, Sun Y, Ji C, et al. Resveratrol improves human umbilical cord-derived mesenchymal stem cells repair for cisplatin-induced acute kidney injury. Cell Death Dis. 2018,20;9(10):965. Yuan T, Guo SC, Han P, Zhang CQ, Zeng BF. Applications of leukocyte-and platelet-rich plasma (L-PRP) in trauma surgery. Curr Pharm Biotechnol. 2012, 13: 1173-84. Franklin JM, Guan KL. YAP/TAZ phase separation for transcription. Nat Cell Biol. 2020,22(4):357-358. Boopathy GTK, Hong WJ. Role of Hippo pathway-YAP/TAZ signaling in angiogenesis. Front Cell Dev Biol. 2019,10;7:49. Kim HY, Kim TJ, Kang L, Kim YJ, Kang MK, Kim J, et al. Mesenchymal stem cell-derived magnetic extracellular nanovesicles for targeting and treatment of Ischemic stroke. Biomaterials. 2020,243:119942. Choi H, Kim Y, Mirzaaghasi A, Heo J, Kim YN, Shin JH, et al. Exosome-based delivery of super-repressor IκBα relieves sepsis-associated organ damage and mortality. Sci Adv. 2020,8;6(15):eaaz6980. Hersant B, Sid-Ahmed M, Braud L, Jourdan M, Baba-Amer Y, Meningaud JP, et al. Platelet-rich plasma improves the wound healing potential of mesenchymal stem cells through paracrine and metabolism alterations. Stem Cells Int. 2019, 31;2019:1234263. Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020, 7;367(6478):eaau6977. Supplementary Files SupplementaryFigurelegends.docx figures2.tif figures3.tif Cite Share Download PDF Status: Posted Version 2 posted You are reading this latest preprint version Show more versions Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-33696","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Research","associatedPublications":[],"authors":[{"id":1051109,"identity":"1440a62b-7eec-4591-b8c7-f227c62a0ccd","order_by":0,"name":"Cheng Ji","email":"","orcid":"","institution":"school of medicine jiangsu university","correspondingAuthor":false,"prefix":"","firstName":"Cheng","middleName":"","lastName":"Ji","suffix":""},{"id":1051110,"identity":"fc3ed4d1-b1c8-4859-b1c4-ee317cb21131","order_by":1,"name":"Jiahui Zhang","email":"","orcid":"","institution":"school of medicine jiangsu university","correspondingAuthor":false,"prefix":"","firstName":"Jiahui","middleName":"","lastName":"Zhang","suffix":""},{"id":1051111,"identity":"2df8e5a1-a906-41f3-9af7-72e8804f1c70","order_by":2,"name":"Zixuan Zhou","email":"","orcid":"","institution":"Jiangsu University","correspondingAuthor":false,"prefix":"","firstName":"Zixuan","middleName":"","lastName":"Zhou","suffix":""},{"id":1051112,"identity":"6528e618-e11f-4d82-b5a3-43d71c487fd4","order_by":3,"name":"Hui Shi","email":"","orcid":"","institution":"school of medicine jiangsu university","correspondingAuthor":false,"prefix":"","firstName":"Hui","middleName":"","lastName":"Shi","suffix":""},{"id":1051113,"identity":"8b1ba794-9d7f-4303-ad8a-7480180f7516","order_by":4,"name":"wanzhu Liu","email":"","orcid":"","institution":"the affilliated people hospital of jiangsu university","correspondingAuthor":false,"prefix":"","firstName":"wanzhu","middleName":"","lastName":"Liu","suffix":""},{"id":1051114,"identity":"aea5eeb7-4a31-4c81-a900-6efeec680400","order_by":5,"name":"Fengtian Sun","email":"","orcid":"","institution":"school of medicine jiangsu university","correspondingAuthor":false,"prefix":"","firstName":"Fengtian","middleName":"","lastName":"Sun","suffix":""},{"id":1051115,"identity":"97316bec-2fe8-4041-8135-89e55c586fbf","order_by":6,"name":"Chenxiao Zhang","email":"","orcid":"","institution":"school of medicine jiangsu university","correspondingAuthor":false,"prefix":"","firstName":"Chenxiao","middleName":"","lastName":"Zhang","suffix":""},{"id":1051116,"identity":"ad01f45e-ae21-46d0-be75-7e115bcf36e6","order_by":7,"name":"Leilei Zhang","email":"","orcid":"","institution":"school of medicine jiangsu university","correspondingAuthor":false,"prefix":"","firstName":"Leilei","middleName":"","lastName":"Zhang","suffix":""},{"id":1051117,"identity":"62473b34-0937-4c82-87ed-e8c112340b59","order_by":8,"name":"Zixun Sun","email":"","orcid":"","institution":"school of medicine jiangsu university","correspondingAuthor":false,"prefix":"","firstName":"Zixun","middleName":"","lastName":"Sun","suffix":""},{"id":1051118,"identity":"93ac7e20-586d-4fe4-ac93-d240a8d75e48","order_by":9,"name":"Hui Qian","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAAtklEQVRIiWNgGAWjYBACPghlwcDA3tj48AMxWtgYmEGUBAMPz+FmYwnStEiktwnwEKWF//zRTTdzJOztJR+2AXXayek2ENIikcx2O3ebRGKPdGLbgwKGZGOzAwS1MIO1JPBIJ7YbSDAcSNxGUAv/YbAWex7Jg20SPERpYYA4jLFHgpFYLRLJZhC/nEkEBrIBEX7h5z/4DKjFxp69/fjDhx8q7OQIakEDBqQpHwWjYBSMglGAAwAA6C86edFAXGAAAAAASUVORK5CYII=","orcid":"https://orcid.org/0000-0002-0098-3196","institution":"School of medicine,Jiangsu University","correspondingAuthor":true,"prefix":"","firstName":"Hui","middleName":"","lastName":"Qian","suffix":""}],"badges":[],"createdAt":"2020-06-05 14:48:03","currentVersionCode":2,"declarations":"","doi":"10.21203/rs.3.rs-33696/v2","doiUrl":"https://doi.org/10.21203/rs.3.rs-33696/v2","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":1765946,"identity":"b714012d-ce9d-4d2f-a605-0923b0bec5f0","added_by":"auto","created_at":"2020-08-03 15:18:39","extension":"jpg","order_by":1,"title":"Figure 1","display":"","copyAsset":false,"role":"figure","size":1004330,"visible":true,"origin":"","legend":"Platelet-rich plasma enhanced the repairing effect of MSCs on glycerin-induced acute kidney injury a. Schematic of AKI model and MSC/PRP-MSC treatment. AKI rats were intravenously injected with MSC/PRP-MSC (1×106/injection) on days 1 and 2, 3. The rats were sacrificed on day 4 for subsequent experiments (n=6). b. Serum BUN and c.) Creatinine levels in glycerin, MSCs, and PRP-MSCs groups (*P \u003c0.05, **P \u003c0.01, and ***P \u003c0.001). d. Representative micrographs of renal HE histology at Day 3 after glycerin injection in the four groups (Scale bars =100μm). e. The degree of tubular damage was scored by choosing 10 non-overlapping fields and calculating the percentage of tubules in the kidney cortex, which exhibited tubular cells necrosis and cast deposition as follows: 0, none; 1, ≤ 10%; 2, 10–25%; 3, 25–50%; 4, 50–75%; and 5, \u003e 75%. The tubular injury score was calculated at Day 3 after glycerin injection (*P \u003c0.05, **P\u003c0.01, ***P\u003c0.001). f. Western blotting analysis of Bax, actived-caspase3 in the kidney tissues at Day 3 after glycerin injection. g. Immunohistochemical staining graph of actived-caspase3 in the glycerin-induced injured kidney sections (Scale bars = 50μm). h. Representative images of TUNEL staining in the kidney sections at Day 3 after PRP-MSCs treatment (Scale bars = 50μm).","description":"","filename":"figure1.jpg","url":"https://assets-eu.researchsquare.com/files/rs-33696/v2/figure1.jpg"},{"id":1765947,"identity":"d2bc6304-a622-4948-b247-bea9a5019e6a","added_by":"auto","created_at":"2020-08-03 15:18:39","extension":"jpg","order_by":2,"title":"Figure 2","display":"","copyAsset":false,"role":"figure","size":765078,"visible":true,"origin":"","legend":"PRP-MSCs attenuated glycerin-induced NRK-52E cells apoptosis a. A schematic of the Transwell coculture model with PRP-MSCs in the upper chamber and NRK-52E cells in the lower chamber of the well. A porous (0.4 µm) membrane allows the transfer of exosomes but precludes direct cell contact. b. Western blotting analysis for Bax, actived-caspase3 expression in NRK-52E cells. c. Flow cytometry detected apoptotic NRK-52E cells with PRP-MSCs treatment. d. The statistical result of apoptotic NRK-52E cells (**P\u003c0.01, ***P\u003c0.001). e. Immunohistochemical staining of actived-caspase3 in glycerin-induced injured NRK-52E cells with PRP-MSCs treatment (Scale bars = 50μm). f. Representative images of TUNEL staining in glycerin-induced injured NRK-52E cells with PRP-MSCs treatment (Scale bars = 50μm).","description":"","filename":"figure2.jpg","url":"https://assets-eu.researchsquare.com/files/rs-33696/v2/figure2.jpg"},{"id":1765948,"identity":"293f6913-e017-40b4-992d-6b8f55996098","added_by":"auto","created_at":"2020-08-03 15:18:39","extension":"jpg","order_by":3,"title":"Figure 3","display":"","copyAsset":false,"role":"figure","size":528719,"visible":true,"origin":"","legend":"PRP promoted the proliferation and differentiation of MSCs\na. Microscope observed the growth of MSC 24 h after PRP stimulation (Scale bars=50μm). b. Immunohistochemical analysis of YAP protein localization in MSCs under PRP stimulation (Scale bars=50μm). c. Western blotting analysis for stemness-associated proteins in MSCs with PRP treatment. d. qRT-PCR analysis the stemness-associated genes of MSCs (**P\u003c0.01, ***P\u003c0.001). e. Adipogenic and osteogenic differentiation capacity after co-culture of MSCs with PRP for 48 h in vitro (Scale bars = 50μm).\n","description":"","filename":"figure3.jpg","url":"https://assets-eu.researchsquare.com/files/rs-33696/v2/figure3.jpg"},{"id":1765949,"identity":"0e84e6c1-07db-42a8-8806-a750a66a7db3","added_by":"auto","created_at":"2020-08-03 15:18:39","extension":"tif","order_by":4,"title":"Figure 4","display":"","copyAsset":false,"role":"figure","size":1462167,"visible":true,"origin":"","legend":"PRP promoted the paracrine secretion of MSCs exosomes though AKT/Rab27 pathway a. Immunofluorescence analysis of AKT and b) Rab27 in MSCs under PRP stimulation (Scale bars = 20μm). c. Western blotting analysis for AKT and Rab27 in MSCs with PRP treatment. d. Western blotting detected the expression of exosomal markers in MSCs treatment with PRP. e. The expression of exosomal marker CD63 (red) in MSCs with PRP treatment was detected by confocal microscope (Scale bars = 10μm). f. The morphology of MSC-Ex/PRP-MSC-Ex was identified by TEM. g. The size and concentration of MSC-Ex/PRP-MSC-Ex were measured by NTA. h. The quantity difference between MSC-Ex/PRP-MSC-Ex was analyzed (**P\u003c0.01).","description":"","filename":"figure4.tif","url":"https://assets-eu.researchsquare.com/files/rs-33696/v2/figure4.tif"},{"id":1765950,"identity":"42fd5c2d-7611-4fd5-81c3-5a77c95c7e56","added_by":"auto","created_at":"2020-08-03 15:18:39","extension":"tif","order_by":5,"title":"Figure 5","display":"","copyAsset":false,"role":"figure","size":3739575,"visible":true,"origin":"","legend":"PRP-MSC-Ex localization and repaired for renal injured tissue\na. Representative fluorescence images of AKI rat injected with DiR-labeled PRP-MSC-Ex, evaluated 12 h after injection. b. Representative micrographs of renal HE histology after MSC-Ex/PRP-MSC-Ex treatment (Scale bars =100μm). c. Immunohistochemical staining graph of actived-caspase3 in the glycerin-induced injured kidney sections (Scale bars = 50μm). d. Western blotting analysis for Bax, actived-caspase3 expression in the kidney tissues after MSC-Ex/PRP-MSC-Ex treatment. e. The statistical result of apoptosis-related proteins in NRK-52E cells (*P\u003c0.05, **P\u003c0.01, ***P\u003c0.001). f. Flow cytometry detected apoptotic NRK-52E cells with PRP-MSC-Ex treatment. g. The statistical result of apoptotic NRK-52E cells with MSC-Ex/PRP-MSC-Ex treatment (*P\u003c0.05, **P\u003c0.01, ***P\u003c0.001). h. Representative immunohistochemical images of actived-caspase3 with PRP-MSC-Ex treatment (Scale bars = 50μm). i. Western blotting analysis for Bax, actived-caspase3 expression in NRK-52E cells after PRP-MSC-Ex intervence. \n","description":"","filename":"figure5.tif","url":"https://assets-eu.researchsquare.com/files/rs-33696/v2/figure5.tif"},{"id":13566888,"identity":"ccb5394f-e5f1-476d-a8f6-62b6fe4417af","added_by":"auto","created_at":"2021-09-17 03:30:46","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":6687339,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-33696/v2/4f7a0cbe-db6b-4252-8dbd-bf7c82c04403.pdf"},{"id":1765952,"identity":"748c1eb1-fa15-42a6-9509-f594f665f748","added_by":"auto","created_at":"2020-08-03 15:18:39","extension":"docx","order_by":1,"title":"","display":"","copyAsset":false,"role":"supplement","size":20889,"visible":true,"origin":"","legend":"","description":"","filename":"SupplementaryFigurelegends.docx","url":"https://assets-eu.researchsquare.com/files/rs-33696/v2/SupplementaryFigurelegends.docx"},{"id":1765953,"identity":"1ec82139-56d3-4b80-82b2-54859c62a10f","added_by":"auto","created_at":"2020-08-03 15:18:40","extension":"tif","order_by":2,"title":"","display":"","copyAsset":false,"role":"supplement","size":1118744,"visible":true,"origin":"","legend":"","description":"","filename":"figures2.tif","url":"https://assets-eu.researchsquare.com/files/rs-33696/v2/figures2.tif"},{"id":1765954,"identity":"8548e333-d4b0-48c9-80ef-41d21cbdcfea","added_by":"auto","created_at":"2020-08-03 15:18:40","extension":"tif","order_by":3,"title":"","display":"","copyAsset":false,"role":"supplement","size":1690454,"visible":true,"origin":"","legend":"","description":"","filename":"figures3.tif","url":"https://assets-eu.researchsquare.com/files/rs-33696/v2/figures3.tif"}],"financialInterests":"","formattedTitle":"\u003cp\u003ePlatelet-rich plasma enhanced MSCs repair for glycerin-induced acute kidney injury via AKT/Rab27 paracrine pathway\u003c/p\u003e","fulltext":[{"header":"Background","content":"\u003cp\u003eAcute renal failure was caused by a variety of factors, including hypoxia, mechanical trauma, surgery, drugs and inflammation, induced the decrease of glomerular filtration rate, the accumulation of blood creatinine, urea nitrogen and other metabolites which was characterized by a rapid deterioration of renal function \u003csup\u003e[1, 2]\u003c/sup\u003e. And resulted in the corresponding clinical manifestations of the syndrome, which was a common clinical critical emergency\u003csup\u003e [3, 4]\u003c/sup\u003e. Although the renal tissue exhibited an intrinsic ability to regenerate after injury, full recovery in most cases was not achieved \u003csup\u003e[5]\u003c/sup\u003e. So that, multiple therapy approaches for renal regeneration have being considered.\u003c/p\u003e\n\u003cp\u003eMesenchymal stem cells (MSCs) have considerable potential in regenerative medicine for their ability of renewal and differentiation into distinct cell types, among the new therapeutic options for AKI, and MSCs were gaining increasing interest for the treatment of kidney injury \u003csup\u003e[6-8]\u003c/sup\u003e. MSCs could be isolated from the bone marrow, umbilical cord, adipose tissues, and other adult tissues \u003csup\u003e[9]\u003c/sup\u003e. Our previous studies have showed hucMSCs could be favourable candidate for injured tissue repair \u003csup\u003e[10, 11]\u003c/sup\u003e. Moreover, the efficacy of stem cell-based therapy could be further improved by small-molecule. Small-molecule drugs have an important role in regulating stem cell fate and function, and facilitate the development of cell-based therapies \u003csup\u003e[12, 13]\u003c/sup\u003e.\u003c/p\u003e\n\u003cp\u003ePlatelet rich plasma (PRP) are fractions of blood plasma with platelet concentrations and the platelet content was 1.2\u0026times;10\u003csup\u003e12\u003c/sup\u003e platelets/ml. PRP contains a lot of cytokines, for instance PDGF, VEGF, TGF-\u0026beta;, IGF-1 and so on \u003csup\u003e[14,15]\u003c/sup\u003e. Recently studies reported that PRP could enhance cell clone formation, maintain the adipogenic, chondrogenic and osteogenic differentiation capacity of stem cells, and maintain an immunosuppressive state \u003csup\u003e[16, 17]\u003c/sup\u003e. Based on these biologic functions, PRP have been widely investigated in regenerative medicine. It was reported that PRP alleviated multiple organs damage, particularly in the skin injury \u003csup\u003e[18, 19]\u003c/sup\u003e. However, the effect of PRP on MSCs-based kidney therapy had not been cleared. It remains unknown whether PRP-modified MSCs could showed a more efficient repairing ability than did MSCs in tissue injury.\u003c/p\u003e\n\u003cp\u003eAs we known glycerin was a kind of high permeable substance and intramuscular injection of glycerin causes local muscle necrosis and erythrolysis, and it was easy to enter renal tubules through glomeruli, caused acute renal tubule damage \u003csup\u003e[20]\u003c/sup\u003e. Therefore, AKI animal model was established by intramuscular injection of 50% solution of hypertonic glycerin. Our previous studies have shown that MCSs have certain advantages in tissue damage repair. Futhermore, there were reported that modified MSCs could play enhanced therapeutic roles in kidney dysfunction diseases. As an endogenous stimulator, PRP could enhance the therapeutic effective of MSCs? What was the mechanism of MSCs repairing injury? In addition, for modulating MSCs function, small stimulator compounds have several advantages, including the convenience in modifying their concentration, working duration, and rapid and reversible working effects.\u003c/p\u003e\n\u003cp\u003eHere we investigated the effect of PRP-MSCs and MSCs on glycerin-induced AKI. Our results showed that PRP induced YAP nucleus expression to promoting proliferation and maintain the stemness of MSCs, and stimulated the paracrine exosomes of MSCs though activated AKT/Rab27 signaling pathway to inhibiting the apoptosis of renal tubular cells. RPP pretreatment may be a new method to improve the therapeutic effect of MSCs repair for glycerin-induced AKI.\u003c/p\u003e"},{"header":"Materials And Methods","content":"\u003cp\u003eThe study was approved by the ethical committee of Jiangsu University (2014280).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eCells Culture\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eFresh human umbilical cords were obtained from consenting mothers in the affiliated hospital of Jiangsu University. HucMSCs were isolated and identified as previously described \u003csup\u003e[11]\u003c/sup\u003e and cultured in serum-free Dulbecco\u0026rsquo;s modified Eagle\u0026rsquo;s medium (DMEM, Gibco, CA) with 10% fetal bovine serum (FBS, Excell), penicillin and streptomycin (Gibco). Platelet-rich plasma (PRP) was provided by the central blood bank of Zhenjiang city, Jiangsu, China. The primary concentration was 1.2\u0026times;10\u003csup\u003e12 \u003c/sup\u003eplatelets/mL. In the following experiments, hucMSCs treated with 1\u0026times;10\u003csup\u003e8\u003c/sup\u003e platelets/mL PRP 12 h, and then the stimulator (PRP medium) was remove, MSCs were cultured in DMEM for 24 hours and collected cells as PRP-MSCs, MSCs: hucMSCs treated with DMEM as the control. Rat renal tubular epithelial cell lines (NRK-52E) were purchased from Cell Bank (Chinese Academy of Sciences, Shanghai, China) and maintained in high-glucose Dulbecco\u0026rsquo;s modified Eagle\u0026rsquo;s medium (DMEM, Gibco) containing 10% FBS at 37℃ with 5% CO\u003csub\u003e2\u003c/sub\u003e. The cells at passage 3 were used for the following studies.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eOsteogenic and adipogenic differentiation in vitro\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eMSCs and PRP-MSCs were seeded in 35-mm plates in an osteogenic differentiation medium (0.1 mM dexamethasone, 10 mM \u0026beta;-glycerophosphate, and 50 mg/L ascorbic acid) or adipogenic differentiation medium (Cyagen Biosciences, USA) for 2 weeks, according to the manufacturer\u0026rsquo;s instructions. After the induction, the osteogenic and adipogenic potential was evaluated through alkaline phosphatase, alizarin red and oil red O staining, respectively.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eIsolation and Characterization of PRP-MSC-Ex\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe supernatant of MSCs stimulated by PRP 12 hours was collected, to a certain volume then exosomes were extracted and purified \u003csup\u003e[21]\u003c/sup\u003e. The protein concentration, as the quantification of exosomes, was determined by using a BCA protein assay kit. The morphology of exosomes was observed by using transmission electron microscopy (FEITecnai 12, Philips, Netherlands). The size of exosomes was analyzed the NanoSight LM10 system (nanosight tracking analysis, UK). For in vivo, to investigate the roles of PRP-MSCs-Ex in AKI model, MSCs-Ex and PRP-MSCs-Ex (10mg/kg) were treatment for AKI model via tail vein injected. CM-DiR (sigma) labeled exosomes were incubated at 37 ℃ for 30 minutes, and the bio-distribution of exosomes was detected via IVIS Lumina system (Perkin Elmer, USA) in vivo.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eGlycerin-induced model of AKI\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eAdult male Sprague-Dawley rats weighing 180-200g (provided by the experimental animal center, JiangSu University, Permit Number: 2014280) were selected, the in vivo experiments were conducted following the regulatory standards. All the experimental rats were reared in the environment of room temperature of about 26 ℃, and the room should be kept clean, ventilated and quiet. After feeding for one week, the experimental rats were divided into four groups according to the random number table: control group, glycerin group, MSCs group, PRP-MSCs group, 10 rats in each group. The AKI rat model was established as described previously\u003csup\u003e [20]\u003c/sup\u003e. As previously described, AKI was performed in rat by intramuscular injection of 50% solution of hypertonic glycerin (10mL/kg, Sigma) into inferior hindlimbs. On day 1 post injury, rat received a tail vein injection of 1\u0026times;10\u003csup\u003e6\u003c/sup\u003e MSCs and 1\u0026times;10\u003csup\u003e6\u003c/sup\u003e PRP-MSCs in 200 mL saline and the same volume of saline as control. All animals were sacrificed at Day 3 after glycerin injection. Renal function (serum BUN, Creatinine), histopathological structure changes and tubular cells apoptosis were evaluated.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eWestern blotting\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eRenal tissues or NRK-52E cells were lysed in a radioimmunoprecipitation assay buffer containing proteinase inhibitors. Protein samples were separated by SDS-polyacrylamide gel electrophoresis, transferred to the polyvinylidene difluoride membrane (Millipore), blocked in 5% skim milk, and incubated with primary antibodies and horseradish peroxidase-conjugated secondary antibodies (Invitrogen).\u003c/p\u003e\n\u003cp\u003ePrimary antibodies used in research were as following: Bax (1:200, Bioworld, USA), Actived-caspase3 (1:500, CST, USA), and \u0026beta;-actin (1:800, CST, USA). The secondary antibodies were HRP-conjugated goat anti-rabbit and goat anti-mouse antibodies (1:1500, CWBIO, China).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eTUNEL and immunohistochemistry staining \u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eFor histologic analysis, the kidneys were prepared by perfusion of the rat through the left ventricle and slides of the kidney were prepared, fixed in 4% paraformaldehyde, embedded in paraffin and then cut into sections. We detected apoptosis cells by employing terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) staining according to the manufacturer\u0026rsquo;s protocol (Vazyme, USA). The sections were stained with hematoxylin and eosin (HE) staining, and the histological changes of renal tissues were observed under a microscope (DP73; Olympus, Tokyo, Japan). After inactivating endogenous enzymes by 10% H\u003csub\u003e2\u003c/sub\u003eO\u003csub\u003e2 \u003c/sub\u003ewith 30 minutes, the slices of kidney tissues and cells were incubated with actived-caspase3 antibody (1:100, CST, USA) overnight at 4\u0026deg;C, then incubated with biotinylated sheep anti-rabbit IgG. The signal was observed by DAB staining and hematoxylin counterstaining under microscope (DP73; Olympus, Tokyo, Japan).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eImmunofluorescence analysis\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eMSCs and PRP-MSCs cells slide were placed in 4% paraformaldehyde at 4\u0026deg;C for 12 h. Then permeabilized with PBS solution containing 0.15% Triton X-100 for 30min and incubated with 5% bovine serum albumin (BSA) for 1h to block non-specific antibody binding. Primary antibody AKT (1:100, CST), Rab27 (1:100, CST), CD63 (exosomes marker) (1:50, CST) were incubated overnight, followed by incubation with Cy3-labeled (Red) anti-rabbit IgG (1: 200, invitrogen), FITC-labeled (Green) anti-rabbit IgG secondary antibody (1: 200, invitrogen) at 37\u0026deg;C for 30 min. The nuclei were counterstained with Hoechst 33342 (1:200; Sigma). The slides were visualized with Confocal microscope (DeltaVision Elite, GE, USA).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eStatistical analysis\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eAll data were shown as mean \u003cstrong\u003e\u0026plusmn;\u003c/strong\u003e SD. Statistical analysis between groups was performed by GraphPad Prism 5.0 software (San Diego, USA). Statistical differences between two groups were determined by two-tailed paired Student\u0026rsquo;s t-test. In multiple groups (\u0026gt;2) were determined by one-way analysis, and variance followed by ANOVA Tukey\u0026rsquo;s post tests. *\u003cem\u003eP\u003c/em\u003e \u0026lt;0.05 was considered statistically significant.\u003c/p\u003e"},{"header":"Results","content":"\u003cp\u003e\u003cstrong\u003ePlatelet-rich plasma enhanced the repairing effect of MSCs on glycerin-induced acute kidney injury\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eIn order to investigate the repairing effect of PRP-MSCs on acute renal injury, we constructed the AKI model by intramuscular injection of 50% hypertonic glycerol solution into the inferior hind limbs of rats (10 mL/kg), and to evaluating the repairing ability of PRP-MSCs in AKI model (Fig. 1a). Results showed that serum BUN and Creatinine levels increased markedly at Day 3 and remained at a high level after 50% glycerin injection. Compared with MSCs, PRP-MSCs transplantation reduced Creatinine levels (Fig. 1b and Fig. 1c). The histological evaluation of kidney sections in the glycerin group revealed the presence of intra-tubular protein casts and tubular epithelial cell necrosis. The number of casts and necrotic tubules was significantly reduced in MSCs and PRP-MSCs-treated rat confirming their beneficial effect, and PRP-MSCs was more effective than MSCs in alleviating the vacuoles of renal tubules (Fig. 1d). Moreover,\u0026nbsp;the histological damage score of PRP-MSCs group was significantly lower than that of glycerin injury group, and the damage score of PRP-MSCs group was 40% lower than MSCs group (Fig. 1e). In rat kidney tissues, we used western blotting to detecting the expression of apoptosis-associated proteins. The results showed that though transplanting MSCs and PRP-MSCs decreased the expression of Bax and actived-caspase3, and the anti-apoptosis effect of PRP-MSCs group was more efficiency than MSCs group (Fig. 1f). In the pathological section of renal tissue, immunohistochemical staining further confirmed the most actived-caspase3 positive cells were glycerin groups, while the number of PRP-MSCs groups was significantly lower than that of MSCs group (Fig. 1g). Furthermore, TUNEL assay indicated that a reduced number of apoptotic cells in both MSCs and PRP-MSCs groups, and the PRP-MSCs group had fewer apoptotic cells than did MSCs group (Fig. 1h). These results indicated that PRP-MSCs showed more efficient repair ability than MSCs in glycerin-induced kidney injury.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003ePRP-MSCs attenuated glycerin-induced NRK-52E cells apoptosis\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eHistopathology showed that AKI mainly damaged renal tubules, therefore，in vitro experiment, we used 20% glycerol hypertonic medium-treated NRK-52E cells. After treating with glycerin for 12 h, there were a significantly increased number of apoptotic NRK-52E cells. Then, we established an in vitro transwell co-culture system to allow the transfer of EVs but to preclude direct cell contact and evaluated the effects of NRK-52E cells treated with the MSCs/PRP-MSCs for 24 hours (Fig. 2a). Then lysis and extraction protein in NRK-52E cells, western blotting analysis the expression of apoptosis-associated proteins and the results showed that Bax and actived-caspase3 significantly increased after glycerin treatment. Nevertheless, in the PRP-MSCs group, the expression levels of Bax and actived-caspase3 were lowest in NRK-52E cell (Fig. 2d). Corresponding\u0026nbsp;to\u0026nbsp;these, treatment with PRP-MSCs or MSCs could effectively reverse cells apoptosis and the number of apoptotic NRK-52E cells was least in the PRP-MSCs group by flow cytometry (Fig. 2c). The statistical result was shown in Fig. 2d. Immunohistochemical and TUNEL staining further confirmed the expression of actived-caspase3 and Bax the results were consistent with that by western blotting. Respectively, the number of actived-caspase3 and TUNEL-positive cells obviously increased after glycerin treatment, PRP-MSCs group had fewer positive cells than did MSCs group (Fig. 2e and 2f). In general, these results showed that PRP-MSCs could significantly inhibit glycerin-induced NRK-52E cells apoptosis compared with MSCs, which confirmed the role of the reno-protective.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003ePRP promoted the proliferation and differentiation of MSCs\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eIn vivo and in vitro experiments, we confirmed the repair effect of PRP-MSCs in AKI model. Then, MSCs treated with 1\u0026times;10\u003csup\u003e8\u003c/sup\u003e platelets/mL PRP 12 h, we observed that PRP could significantly promote the proliferation of MSCs (Fig. 3a). Being a key pathway involved in regeneration progression, YAP signaling controls organ size and regulates tissue cell regeneration \u003csup\u003e[22, 23]\u003c/sup\u003e. Immunohistochemistry showed that PRP induced YAP nucleus expression and promoted cell proliferation in MSCs (Fig. 3b). Then, we used western blotting and qRT-PCR analysis for stemness-associated proteins expression, at protein and gene level of Nanog, Sox2, Oct4 and Sall4 were increased in MSCs with PRP treatment (Fig. 3c and 3d). In vitro experiments, PRP induced adipogenic and osteogenic differentiation of MSCs, and the percentage of alizarin red positive cells in PRP group was higher than DMEM group, confirmed PRP could promote multi-directional differentiation of MSCs (Fig. 3e). Overall,\u0026nbsp;these\u0026nbsp;results\u0026nbsp;suggest\u0026nbsp;that PRP induced YAP nucleus expression and increased stemness-associated gene to promoting MSCs proliferation and differentiation.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003ePRP promoted the paracrine secretion of MSCs exosomes though AKT/Rab27 pathway\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eIt is confirmed that PRP could promoted the proliferation and repair AKI of MSCs. Next, we explored the mechanism of PRP enhanced the repair of MSCs, recently research have reported that MSC exosomes (MSC-Ex) were the key paracrine component of MSCs, and shown to exert therapeutic effects on tissue injury \u003csup\u003e[24, 25]\u003c/sup\u003e. Therefore, we focused on the effect of PRP on the exosomes secretion of MSCs. AKT/Rab27 signaling pathway regulated the synthesis and secretion of exosomes \u003csup\u003e[26]\u003c/sup\u003e, in this experiment, our found that PRP stimulated AKT to enter the nucleus and the expression of Rab27 was increased (Fig. 4a and 4b). In the other side, the protein level of PRP-MSCs confirmed this result (Fig. 4c). Western blot results confirmed the higher expression of exosomal marker CD9, CD63 and CD81 in PRP-MSC-Ex (Fig. 4d). PRP stimulated the increase of CD63 in MSCs was observed with confocal microscope, which indicated that PRP promoted the secretion of exosomes (Fig. 4e). These results suggested that PRP might affect the secretion of MSC exosomes. We further analyzed, exosomes as cup-like spherical vesicles by using transmission electron microscopy (TEM) (Fig. 4f), MSC-Ex as nanoscale membrane vesicles, the size was determined to be 101.5 \u0026plusmn; 24.3nm and PRP-MSC-Ex was 108.6 \u0026plusmn; 33.6nm (mean \u0026plusmn; SD) by nanoparticle tracking analysis (NTA), diluted 1000 times when measuring, so the concentration of MSC-Ex was 2.5\u0026times;10\u003csup\u003e9\u003c/sup\u003e/ml and PRP-MSC-Ex was 5.1\u0026times;10\u003csup\u003e9\u003c/sup\u003e/ml (Fig. 4g), and we found the shape and particle size of exosomes not changed by PRP stimulation, while PRP could increased the secretion of MSC-Ex twice (Fig. 4h). These results indicated that PRP promoted the paracrine secretion exosomes of MSCs though activated AKT/Rab27 pathway.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003ePRP-MSC-Ex localization and repaired for renal injured tissue\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eTo determine the localization and bio-distribution of PRP-MSCs-Ex within injured renal tissue, exosomes were labeled with a fluorescent dye (DIR, 50\u0026mu;M) were injected intravenously and tracked by optical imaging (PerkinElmer, USA) in AKI mice. The performed 12 h after the administration of exosomes, revealed the presence of exosomes fluorescence signal in injury kidneys (Fig. 5a and Fig. S2a).\u0026nbsp;Previously, we confirmed the orientation of exosomes in damaged tissues, next step we analyzed the role of the reno-protective factor. Compared with MSCs-Ex, PRP-MSCs-Ex transplantation reduced Bun and Creatinine levels in AKI model (Fig. S1c and Fig. S1d). Kidney histological revealed that the number of casts and necrotic tubules was significantly reduced in MSC-Ex and PRP-MSC-Ex treated rats (Fig. 5b). Similarly, the TUNEL analysis showed that the number of apoptotic cells in MSC-Ex group and PRP-MSC-Ex group were decreased, and the number of apoptotic cells in PRP-MSC-Ex group was significantly less than that in glycerin group (Fig. 5c). The expression of apoptosis-related proteins Bax and Actived-caspase3 in renal tissue were inhibited after PRP-MSC-Ex treatment (Fig. 5d). And the statistical analysis of the intervention effect of PRP-MSC-Ex was better than that of MSC-Ex group (Fig. 5e). In vitro experiments, flow cytometry results showed that MSC-Ex could effectively reduce the apoptosis of NRK-52E cells induced by glycerin, and the number of NRK-52E cells in PRP-MSC-Ex group decreased by 76.3% (Fig. 5f and 5g). In order to further determine this phenomenon, immunohistochemistry was used to detected the expression of activated-caspase3 positive cells after intervention, the number of positive cells in PRP-MSC-Ex group was significantly less than in injury group, and the positive cells were less than the MSC-Ex group (Fig. 5h). Western blotting results showed that the expression of Bax and actived-caspase3 decreased significantly after MSC-Ex treatment. Moreover, in PRP-MSC-Ex group, Bax and actived-caspase3 had the lowest expression level in NRK-52E cells (Fig. 5i). These results confirmed that the PRP-MSC-Ex had more beneficial effect compare with PRP-MSC. In general, these results showed that exosomes were the key component of MSC in the treatment of renal injury which could significantly inhibited the apoptosis of NRK-52E cells induced by glycerin, and confirmed the mechanism of PRP stimulated the secretion exosomes of MSC in the repair of acute renal injury.\u003c/p\u003e"},{"header":"Discussion","content":"\u003cp\u003eKidney injury treatments have always been the intractable medical problem. The therapeutic methods so far were function-limited and if the treatment intervention was not timely, could deteriorate into chronic kidney disease, and many patients suffer from chronic pain for a long time \u003csup\u003e[27]\u003c/sup\u003e. Cell-based therapies and tissue regeneration are new approach to overcome the present limitations of kidney injury healing \u003csup\u003e[28, 29]\u003c/sup\u003e. MSCs were a promising therapeutic tool in regenerative medicine due to their self-renewal and multi-directional differentiation potency. Recently have a large number of studies showed that MSCs could repair cisplatin/glycerin-induced acute kidney injury \u003csup\u003e[30]\u003c/sup\u003e, ischemia/reperfusion-induced acute renal failure \u003csup\u003e[31]\u003c/sup\u003e, and unilateral ureteral obstruction-induced renal interstitial fibrosis \u003csup\u003e[32]\u003c/sup\u003e. Nevertheless, the transplanted MSCs also existed potential problem, most of them could not survive for a long time, only a few of them exist in the damaged kidney. The lower implantation and survival rates weakened the therapeutic effect of MSCs treatment. Therefore, in order to maximize the clinical application value of MSCs, we must take corresponding strategies to improve their therapeutic effect.\u003c/p\u003e\n\u003cp\u003eOne of the common strategies that improved the therapeutic effects of stem cell transplantation was pretreatment stem cells with small molecules drugs. Our recently studies showed that 3,3'-diindolylmethane stimulated exosomal Wnt11 autocrine signaling in MSCs to enhance wound healing \u003csup\u003e[11] \u003c/sup\u003eand resveratrol improved MSCs repair for cisplatin-induced AKI \u003csup\u003e[33]\u003c/sup\u003e. These studies proved that small-molecule drugs were potential candidates for stem cell manipulation in regenerative medicine.\u003c/p\u003e\n\u003cp\u003eThe effect of Platelet-rich plasma (PRP) on tissue healing has been mainly attributed to release of growth factors from platelets, such as PDGF, VEGF and TGF-\u0026beta; could promote cell proliferation and migration \u003csup\u003e[34]\u003c/sup\u003e. Recently, studies have reported that PRP could attract MSCs, then PRP enhanced cells repair and promote the initial healing of wounds and this phenomenon called the chemotactic effect \u003csup\u003e[18]\u003c/sup\u003e. However, the role of PRP pre-treatment in MSCs based therapy has not been characterized. In this study, we found that PRP-MSC improved renal function compared with MSC, as demonstrated by the decrease of serum creatinine and BUN levels, PRP stimulated MSC could inhibit apoptosis of renal tubular cells and as well as the decrease of histological injury score. MSC primed with PRP exhibited more effective repair effects than untreated MSC in glycerin-induced AKI models. These\u0026nbsp;results\u0026nbsp;indicated\u0026nbsp;that PRP pre-treatment was safe, efficient and low cost, which was expected to emerge as a promising strategy to improve MSC-based therapy. The next step was to thinking about the mechanism of PRP promoting MSC to repair renal injury. As we know, YAP plays a key role in the control of tissue and cell proliferation and development \u003csup\u003e[22, 35, 36]\u003c/sup\u003e. Through the experiments PRP stimulated YAP protein to enter the nucleus which promoted the proliferation of MSC and the differentiation ability of osteoblasts and adipocytes. These information were suggested that appropriate amount of PRP could enhance the injury repair effective of MSC.\u003c/p\u003e\n\u003cp\u003eExosomes, one form of extracellular vesicles, have potential as mediators of intercellular message and play a major role in cell-to-cell communication, while therapeutic effects of human MSC-derived exosomes have been verified using a rodent model \u003csup\u003e[21, 37, 38]\u003c/sup\u003e. And then research team finding platelet-rich plasma improved the wound healing potential of mesenchymal stem cells through paracrine and metabolism alterations \u003csup\u003e[39]\u003c/sup\u003e. AKT/Rab27 pathway was involved in the regulation of exosomes synthesis and secretion \u003csup\u003e[26, 40]\u003c/sup\u003e. In this experiment, we found that PRP could increase two times number of MSC exsomes, without changing its morphology and particle size. And PRP stimulated paracrine secretion of MSCs exosomes by activating AKT/Rab27 pathway, DiR dye-labeled PRP-MSCs-Ex localized within the injured kidney and promoted the recovery of renal function, reduced the expression of injury markers.\u003c/p\u003e\n\u003cp\u003eIn the present study, we demonstrate that PRP induced YAP nucleus expression to promoting the proliferation and maintain the stemness of MSCs, and stimulated the paracrine secretion exosomes of MSCs to inhibiting the apoptosis of renal tubular cells by activating AKT/Rab27 signaling pathway. We propose an innovative use of PRP-MSC as a therapeutic strategy for renal regeneration.\u003c/p\u003e"},{"header":"Conclusion","content":"\u003cp\u003eThis study reveals that PRP promoted the paracrine secretion of exosomes by MSCs to repair glycerin-induced AKI though AKT/Rab27 pathway. These findings confirm that RPP pretreatment could improved the therapeutic effect of MSCs on renal injury.\u003c/p\u003e"},{"header":"Declarations","content":"\u003cp\u003e\u003cstrong\u003eAcknowledgements\u003cbr /\u003e\u003c/strong\u003eThis work was supported by the National Natural Science Foundation of China (Grant no. 81871496), Zhenjiang Key Laboratory of High Technology Research on Exosomes Foundation and Transformation Application (Grant ss2018003), Key project of practice and innovation of college students in Jiangsu Province (201910299029Z), and project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (Phase III).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eFunding\u003c/strong\u003e\u003cbr /\u003e The National Natural Science Foundation of China (Grant no. 81871496); Zhenjiang Key Laboratory of High Technology Research on Exosomes Foundation and Transformation Application (Grant no. ss2018003).\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAvailability of data and materials\u003c/strong\u003e\u003cbr /\u003e Not applicable.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAuthors\u0026rsquo; contributions\u003c/strong\u003e\u003cbr /\u003e CJ: conception and design, collection and assembly of data, and manuscript writing. JZ: conception and design, data analysis and interpretation, and manuscript writing. XZ: conception and design, data analysis. HS: collection and/or assembly of data and data analysis. WL: collection and/or assembly of data and data analysis. FS: data analysis and interpretation. CZ: provision of study material and interpretation. LZ: data analysis and interpretation. XZ: data analysis and interpretation. HQ: study design, manuscript writing, and final approval of manuscript.\u003c/p\u003e\n\u003cp\u003eAll authors read and approved the final manuscript.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConflict of interest\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe authors declare that they have no conflict of interest.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConsent for publication\u003c/strong\u003e\u003cbr /\u003e Not applicable.\u003c/p\u003e\n\u003cp\u003e\u003cbr /\u003e\u003cstrong\u003eEthical approval and consent to participate\u003c/strong\u003e\u003cbr /\u003e This study was approved by the ethical committee of Jiangsu University (2014280).\u003c/p\u003e"},{"header":"Abbreviations","content":"\u003cp\u003ePlatelet-rich plasma (PRP)\u003c/p\u003e\n\u003cp\u003eMesenchymal stem cells (MSCs)\u003c/p\u003e\n\u003cp\u003eAcute kidney injury (AKI)\u003c/p\u003e\n\u003cp\u003eMesenchymal stem cells-exosomes (MSCs-Ex)\u003c/p\u003e\n\u003cp\u003eQuantitative real-time polymerase chain reaction (qRT-PCR)\u003c/p\u003e\n\u003cp\u003eNanoparticle tracking analysis (NTA)\u003c/p\u003e\n\u003cp\u003eImmunohistochemistry (IHC)\u003c/p\u003e"},{"header":"References","content":"\u003col\u003e\n\u003cli\u003eSchrier RW, Wang W, Poole B, Mitra A. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest. 2004. 114, 5-14.\u003c/li\u003e\n\u003cli\u003eThiele RH, Isbell JM, Rosner MH. AKI associated with cardiac surgery. Clin J Am Soc Nephrol. 2015,10, 500-514.\u003c/li\u003e\n\u003cli\u003eRewa O, Bagshaw SM. Acute kidney injury-epidemiology, outcomes and economics. Nat Rev Nephrol. 2014.10, 193-207.\u003c/li\u003e\n\u003cli\u003ePozzoli S, Simonini M, Manunta P. Predicting acute kidney injury: current status and future challenges. J Nephrol. 2018. 31, 209-223.\u003c/li\u003e\n\u003cli\u003eAnathhanam S, Lewington AJP. Acute Kidney Injury. J R Coll Physicians Edinb. 2013;43(4):323-8; quiz 329.\u003c/li\u003e\n\u003cli\u003eWang BY, Jia HY, Zhang B, Wang JJ, Ji C, Zhu XM, et al. Pre-incubation with hucMSC-exosomes prevents cisplatin-induced nephrotoxicity by activating autophagy. Stem Cell Res Ther. 2017,8;8(1):75.\u003c/li\u003e\n\u003cli\u003eSwaminathan M, Stafford-Smith M, Chertow GM, Warnock DG, Paragamian V, Brenner RM, et al. Allogeneic mesenchymal stem cells for treatment of AKI after cardiac surgery. J Am Soc Nephrol. 2018, 29, 260-267.\u003c/li\u003e\n\u003cli\u003eYuan X, Wang X, Chen C, Zhou J, Han M. Bone mesenchymal stem cells ameliorate ischemia/reperfusion-induced damage in renal epithelial cells via microRNA-223. Stem Cell Res Ther. 2017, 8, 146.\u003c/li\u003e\n\u003cli\u003eJiang Y, Jahagirdar BN. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002,418:41-49.\u003c/li\u003e\n\u003cli\u003eZhang B, Shi Y, Gong A, Pan Z, Shi H, Yang H, et al. HucMSC exosome-delivered 14-3-3\u0026zeta; orchestrates self-control of the wnt Response via modulation of YAP during cutaneous regeneration. Stem Cells. 2016;34(10):2485-2500\u003c/li\u003e\n\u003cli\u003eShi H, Xu X, Zhang B,Xu J, Pan Z, Gong A, et al. 3,3'-Diindolylmethane stimulates exosomal Wnt11 autocrine signaling in human umbilical cordmesenchymal stem cells to enhance wound healing. Theranostics. 2017,10;7(6):1674-1688.\u003c/li\u003e\n\u003cli\u003eSchugar RC, Robbins PD, Deasy BM. Small molecules in stem cell self- renewal and differentiation. Gene Ther. 2008,15, 126-135.\u003c/li\u003e\n\u003cli\u003eLi W, Li K, Wei W. Chemical approaches to stem cell biology and therapeutics. Cell Stem Cell. 2013,13:270-283.\u003c/li\u003e\n\u003cli\u003eBoswell SG, Cole BJ, Sundman EA, Karas V, Fortier LA. Platelet-rich plasma: a milieu of bioactive factors. Arthroscopy. 2012, 28(3): 429-439.\u003c/li\u003e\n\u003cli\u003eEmer J. Platelet-rich plasma (PRP): current applications in dermatology. Skin Therapy Lett. 2019,24(5):1-6.\u003c/li\u003e\n\u003cli\u003eDuan J, Kuang W, Tan J, Li H, Zhang Y, Hirotaka K, et al. Differential effects of platelet rich plasma and washed platelets on the proliferation of mouse MSC cells. Mol Biol Rep. 2011, 38(4): 2485-2490.\u003c/li\u003e\n\u003cli\u003eLi H, Usas A, Poddar M, Chen CW, Thompson S, Ahani B, et al. Platelet-rich plasma promotes the proliferation of human muscle derived progenitor cells and maintains their stemness. PLoS One. 2013, 8(6): 64923.\u003c/li\u003e\n\u003cli\u003eGuo S, Tao S, Yin W, Qi X, Yuan T, Zhang C. Exosomes derived from platelet-rich plasma promote the re-epithelization of chronic cutaneous wounds via activation of YAP in a diabetic rat model. Theranostics. 2017,1;7(1):81-96.\u003c/li\u003e\n\u003cli\u003eEmer J. Platelets in wound healing and regenerative medicine. Platele. 2018, 29(6):556-568.\u003c/li\u003e\n\u003cli\u003eGrange C, Papadimitriou E, Dimuccio V, Pastorino C, Molina J, O'Kelly R, et al. Urinary extracellular vesicles carrying klotho improve the recovery of renal function in an acute tubular injury model. Mol Ther. 2020, 5;28(2):490-502.\u003c/li\u003e\n\u003cli\u003eSun Y, Shi H, Yin S, Ji C, Zhang X, Zhang B, et al. Human mesenchymal stem cell derived exosomes alleviate type 2 diabetes mellitus by reversing peripheral insulin resistance and relieving \u0026beta;-cell destruction. ACS Nano. 2018,12, 7613-7628.\u003c/li\u003e\n\u003cli\u003eYu FX, Zhao B, Guan KL. Hippo pathway in organ size control, tissuehomeostasis, and cancer. Cell.2015,163,811-828.\u003cbr /\u003e 23. Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, et al. Role of YAP/TAZ in mechanotransduction. Nature. 2011,474:179-183.\u003c/li\u003e\n\u003cli\u003eRiazifar M, Mohammadi MR, Pone EJ, Yeri A, L\u0026auml;sser C, Segaliny AI, et al. Stem cell-derived exosomes as nanotherapeutics for autoimmune and neurodegenerative disorders. ACS Nano. 2019,13(6):6670-6688.\u003c/li\u003e\n\u003cli\u003eYan Y, Jiang W, Tan Y, Zou S, Zhang H, Mao F, et al. HucMSC exosome-derived GPX1 is required for the recovery of hepatic oxidant injury. Mol Ther. 2017,1;25(2):465-479.\u003c/li\u003e\n\u003cli\u003eOstrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A, et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol. 2010,12(1):19-30.\u003c/li\u003e\n\u003cli\u003eXu L, Li X, Zhang F, Wu L, Dong Z, Zhang D. EGFR drives the progression of AKI to CKD through HIPK2 over expression. Theranostics. 2019,13;9(9):2712-2726.\u003c/li\u003e\n\u003cli\u003eLi W, Li K, Wei W. Chemical approaches to stem cell biology and therapeutics.\u003cbr /\u003e Cell Stem Cell. 2013;13:270-283.\u003c/li\u003e\n\u003cli\u003eBarbara F, Griffin MD. Mesenchymal stromal cell-based therapies for acute kidney injury: Progress in the last decade. Kidney Int. 2020. 29;S0085-2538(20)30093-4.\u003c/li\u003e\n\u003cli\u003eFazekas B, Griffin MD. Mesenchymal stromal cell-based therapies for acute kidney injury: progress in the last decade. Kidney Int. 2020,97(6):1130-1140.\u003c/li\u003e\n\u003cli\u003eCao HM, Cheng YQ, Gao HQ, Zhuang J, Zhang W, Bian Q, et al. In vivo tracking of mesenchymal stem cell-derived extracellular vesicles improving mitochondrial function in renal ischemia-reperfusion injury. ACS Nano. 2020,28;14(4):4014-4026.\u003c/li\u003e\n\u003cli\u003eJi C, Zhang J, Zhu Y, Shi H, Yin S, Sun F, et al. Exosomes derived from hucMSC attenuate renal fibrosis through CK1\u0026delta;/\u0026beta;-TRCP-mediated YAP degradation. Cell Death Dis. 2020,7;11(5):327.\u003c/li\u003e\n\u003cli\u003eZhang R, Yin L, Zhang B, Shi H, Sun Y, Ji C, et al. Resveratrol improves human umbilical cord-derived mesenchymal stem cells repair for cisplatin-induced acute kidney injury. Cell Death Dis. 2018,20;9(10):965.\u003c/li\u003e\n\u003cli\u003eYuan T, Guo SC, Han P, Zhang CQ, Zeng BF. Applications of leukocyte-and platelet-rich plasma (L-PRP) in trauma surgery. Curr Pharm Biotechnol. 2012, 13: 1173-84.\u003c/li\u003e\n\u003cli\u003eFranklin JM, Guan KL. YAP/TAZ phase separation for transcription. Nat Cell Biol. 2020,22(4):357-358.\u003c/li\u003e\n\u003cli\u003eBoopathy GTK, Hong WJ. Role of Hippo pathway-YAP/TAZ signaling in angiogenesis. Front Cell Dev Biol. 2019,10;7:49.\u003c/li\u003e\n\u003cli\u003eKim HY, Kim TJ, Kang L, Kim YJ, Kang MK, Kim J, et al. Mesenchymal stem cell-derived magnetic extracellular nanovesicles for targeting and treatment of Ischemic stroke. Biomaterials. 2020,243:119942.\u003c/li\u003e\n\u003cli\u003eChoi H, Kim Y, Mirzaaghasi A, Heo J, Kim YN, Shin JH, et al. Exosome-based delivery of super-repressor I\u0026kappa;B\u0026alpha; relieves sepsis-associated organ damage and mortality. Sci Adv. 2020,8;6(15):eaaz6980.\u003c/li\u003e\n\u003cli\u003eHersant B, Sid-Ahmed M, Braud L, Jourdan M, Baba-Amer Y, Meningaud JP, et al. Platelet-rich plasma improves the wound healing potential of mesenchymal stem cells through paracrine and metabolism alterations. Stem Cells Int. 2019, 31;2019:1234263.\u003c/li\u003e\n\u003cli\u003eKalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020, 7;367(6478):eaau6977.\u003c/li\u003e\n\u003c/ol\u003e"}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"platelet-rich plasma, MSCs, AKT/Rab27, exosomes, AKI","lastPublishedDoi":"10.21203/rs.3.rs-33696/v2","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-33696/v2","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003e\u003cstrong\u003eBackground: \u003c/strong\u003eAcute kidney injury (AKI) was defined by rapid deterioration of renal function, as a common complication in hospitalized patients. Among the recent therapeutic options, mesenchymal stem cells (MSCs) were considered a promising therapeutic strategy for damaged tissues repair. Platelet rich plasma (PRP) regulates stromal cells to repair tissue damage through the release of growth factors. Here we proposed a possible therapeutic use of human umbilical cord mesenchymal stem cells stimulated by platelet-rich plasma (PRP-MSCs) in glycerin-induced acute kidney injury murine model.\u003c/p\u003e\u003cp\u003e\u003cstrong\u003eMethods: \u003c/strong\u003eIn vivo, we constructed glycerin-induced acute kidney injury rat models. On day 1 post injury, rat received a tail vein injection of 1×10\u003csup\u003e6\u003c/sup\u003e MSCs and 1×10\u003csup\u003e6 \u003c/sup\u003ePRP-MSCs. All animals were sacrificed at Day 3 after glycerin injection. In vitro, NRK-52E cells were damaged by 20% glycerol for 12 hours, after that NRK-52E incubated with MSCs and PRP-MSCs for 24 hours in transwell co-culture system, DMEM as a negative control. NRK-52E cells were harvested for apoptosis assay, Western blot, and quantitative real-time polymerase chain reaction (qRT-PCR). Then the number of MSCs exosomes stimulated by PRP was detected by confocal microscopy and Nanosight tracking analysis (NTA), PRP-MSCs-Ex (10mg/kg) and MSCs-Ex (10mg/kg) were injected intravenously, saline as control. The therapeutic effect of PRP-MSCs was evaluated by analyzing renal function (serum BUN, Creatinine), histopathological structure changes and apoptosis and proliferation of renal tubular cells. \u003c/p\u003e\u003cp\u003e\u003cstrong\u003eResults: \u003c/strong\u003eIn vivo and vitro studies confirmed that the PRP induced YAP nucleus expression to promoting the proliferation and reinforces the stemness of MSCs, and PRP could promoted the paracrine secretion of exosomes by MSCs to repair AKI though AKT/Rab27 pathway.\u003c/p\u003e\u003cp\u003e\u003cstrong\u003eConclusions:\u003c/strong\u003e Our results revealed that PRP stimulated MSCs paracrine pathway could effectively alleviate glycerin-induced acute kidney injury. Therefore, RPP pretreatment may be a new method to improve the therapeutic effect of MSCs.\u003c/p\u003e","manuscriptTitle":"Platelet-rich plasma enhanced MSCs repair for glycerin-induced acute kidney injury via AKT/Rab27 paracrine pathway","msid":"","msnumber":"","nonDraftVersions":[{"code":2,"date":"2020-08-03 15:18:02","doi":"10.21203/rs.3.rs-33696/v2","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}},{"code":1,"date":"2020-06-12 19:10:39","doi":"10.21203/rs.3.rs-33696/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"230ed18f-1848-4a46-9703-b8417a42e90b","owner":[],"postedDate":"August 3rd, 2020","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[{"id":234179,"name":"Critical Care \u0026 Emergency Medicine"}],"tags":[],"updatedAt":"2020-08-04T16:28:23+00:00","versionOfRecord":[],"versionCreatedAt":"2020-08-03 15:18:02","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v2","identity":"rs-33696","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-33696","identity":"rs-33696","version":["v2"]},"buildId":"0U-iFTyB6qxOgVj8rjrZV","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}